📰 Risk Evaluation News
Page 37 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
April 11, 2023
Mifepristone is commonly used across the US to end pregnancy. It’s politically controversial, but medical experts say it’s extremely safe.
April 11, 2023
This factsheet provides an overview of medication abortion, with a focus on federal and state regulations pertaining to its provision and coverage, and the role of the drug in self-managed abortions.
April 11, 2023
Adding patient-specific comorbidities improved the prognostic effect of risk prediction models for patients with primary or secondary myelofibrosis, according to findings from an assessment of data collected in Vanderbilt’s Synthetic Derivative and BioVU Biobank comprehensive electronic health record.
April 10, 2023
MONDAY, April 10, 2023 (HealthDay News) -- A Texas federal judge has issued a preliminary ruling that invalidates the U.S. Food and Drug Administration approval in 2000 of mifepristone, the
April 10, 2023
In an unprecedented decision, a federal judge in Texas ruled April 7 to suspend the FDAs decadeslong approval of one of the two abortion pills, mifepristone, effective April 14.
April 10, 2023
The nonprofit Verité has published an open-source toolkit designed to help businesses and other stakeholders detect, prevent and address labor violations within the coffee sector.
April 10, 2023
The Justice Department has asked a federal judge to clarify "significant tension" between his ruling on an abortion drug and another federal judges decision about the same thing.
April 10, 2023
On Friday, Attorney General Ellen Rosenblum announced that a federal judge in Washington state barred the Food & Drug Administration (FDA) from doing anything to reduce the availability of the